지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.108 No.1
- 발행연도
- 2025.1
- 수록면
- 20 - 30 (11page)
이용수
초록· 키워드
오류제보하기
Purpose: This study investigated epidemiologic features of patients with pancreatic cancer in Korea, according to the histologic subtypes.
Methods: The Korea Central Cancer Registry data on patients with pancreatic cancer from 1999 to 2019 were reviewed. The 101,446 patients with pancreatic cancer (C25 based on the International Classification of Diseases, 10th revision) were allocated according to the following morphological codes: A, endocrine; B, carcinoma excluding cystic and mucinous; C, cystic or mucinous; D, acinar cell; and E, sarcoma and soft tissue tumor.
Results: The distribution of each pancreatic cancer subtype group in Korea from 1999 to 2019 was as follows: A, n = 3,101 (3.1%); B, n = 95,051 (93.7%); C, n = 2,856 (2.8%); D, n = 299 (0.3%); and E, n = 139 (0.1%). In group B, 49.2% of patients were aged >70 years, and half of them did not receive treatment within 4 months of diagnosis. In addition, only 30.9% of the patients were in the localized and regional stage in which surgical treatment was possible. Pancreatic cancer occurred more frequently in females than in males only in group C. Between 1999 and 2019, the average annual percentage changes in the age-specific incidence rates were positive in groups A (13.9%, P < 0.001), B (1.0%, P < 0.001), and C (6.5%, P = 0.025). Significant improvements in 5-year survival rates over time were observed in subtypes A, B, and C.
Conclusion: The subgroups of pancreatic cancer show different epidemiologic features, including incidences, treatment rates, and prognoses.
Methods: The Korea Central Cancer Registry data on patients with pancreatic cancer from 1999 to 2019 were reviewed. The 101,446 patients with pancreatic cancer (C25 based on the International Classification of Diseases, 10th revision) were allocated according to the following morphological codes: A, endocrine; B, carcinoma excluding cystic and mucinous; C, cystic or mucinous; D, acinar cell; and E, sarcoma and soft tissue tumor.
Results: The distribution of each pancreatic cancer subtype group in Korea from 1999 to 2019 was as follows: A, n = 3,101 (3.1%); B, n = 95,051 (93.7%); C, n = 2,856 (2.8%); D, n = 299 (0.3%); and E, n = 139 (0.1%). In group B, 49.2% of patients were aged >70 years, and half of them did not receive treatment within 4 months of diagnosis. In addition, only 30.9% of the patients were in the localized and regional stage in which surgical treatment was possible. Pancreatic cancer occurred more frequently in females than in males only in group C. Between 1999 and 2019, the average annual percentage changes in the age-specific incidence rates were positive in groups A (13.9%, P < 0.001), B (1.0%, P < 0.001), and C (6.5%, P = 0.025). Significant improvements in 5-year survival rates over time were observed in subtypes A, B, and C.
Conclusion: The subgroups of pancreatic cancer show different epidemiologic features, including incidences, treatment rates, and prognoses.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Pancreatic Cancer
대한외과학회 학술대회 초록집
2021 .11
-
췌장암 조기진단을 위한 조건부 확률 기반 지능형 진단 방식
의공학회지
2017 .01
-
A Case of Five-Year Survival in Metastatic Pancreatic Cancer
대한췌담도학회지
2024 .07
-
Surgical Treatment for Elderly Patients with Pancreatic Cancer
대한외과학회 학술대회 초록집
2022 .11
-
20대 젊은 남자에서 발병한 췌장암
대한내과학회지
2020 .02
-
Current status of pancreatic cancer treatment in China
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Preoperative treatment for pancreatic cancer
대한외과학회 학술대회 초록집
2016 .11
-
Surgical Management of the Elderly Patient with Pancreatic Cancer
대한외과학회 학술대회 초록집
2022 .11
-
급성췌장염으로 첫 임상 발현한 1A 병기 췌장암
대한내과학회지
2019 .12
-
Incidence, mortality and survival of gallbladder, extrahepatic bile duct, and pancreatic cancer using Korea central cancer registry database: 1999-2019
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .08
-
Mutations of p53 associated with pancreatic cancer and therapeutic implications
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .08
-
Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
대한췌담도학회지
2020 .01
-
Meta-analysis of pancreatic re-resection for locally recurrent pancreatic cancer following index pancreatectomy
Annals of Hepato-Biliary-Pancreatic Surgery
2024 .08
-
Extended versus peripancreatic lymph node dissection for the treatment of left-sided pancreatic cancer
Annals of Surgical Treatment and Research
2017 .06
-
Can Localized Stenosis of the Main Pancreatic Duct be a Predictive Factor for Early Detection of Pancreatic Cancer?
Clinical Endoscopy
2019 .01
-
Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data
Annals of Hepato-Biliary-Pancreatic Surgery
2018 .11
-
Metformin May Improve the Prognosis of Patients with Pancreatic Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Pancreatic metastases mimicking primary pancreatic cancer : A case report
한국간담췌외과학회 학술대회지
2016 .04
-
Multi-center (-National) Studies for Pancreatic Cancer in Korea
대한외과학회 학술대회 초록집
2017 .11
-
Pancreatic tuberculosis revealed by a pancreatic mass
대한외과학회 학술대회 초록집
2017 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-25-02-092317835